This article is more than 5 years old. Information may no longer be current.

Aesculap begins market evaluation of new advanced knee replacement technology

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Aesculap announced in a press release that its VEGA System, an advanced knee replacement technology system, was recently cleared for marketing by the FDA. The VEGA System offers advanced knee replacement technologies, including multilayer coating and a unique kinematic design, the company reported.

The market evaluation phase commenced in November 2010 with the first surgery. Early clinical results are positive with further evaluation ongoing, Aesculap said. The market evaluation is estimated to conclude in the 1st Quarter of 2011 with anticipated market availability in the 3rd quarter 2011. The company is also preparing to begin evaluations in Europe and Asia later this year, according to the press release.